20103 results for «»
20103 results
Primary left ventricular unloading in anterior STEMI without cardiogenic shock: Results from the STEMI-Door to Unload randomized clinical trial
28 Mar 2026
Elad Asher provides his take on the STEMI-DTU trial, which was presented by Navin K. Kapur at the ACC.26 in New Orleans, and simultaneously published in the JACC.
Author
A prospective multicenter registry to define coronary vasomotor disorders in ischemia with nonobstructive coronary arteries: Primary results of DISCOVER INOCA
28 Mar 2026
Aaysha Cader interviews Samit M. Shah, who presented the primary results of the DISCOVER INOCA registry at ACC.26.
Author
Author
Coronary OCT and CMR imaging to determine sex differences in underlying causes of myocardial infarction with no obstructive coronary arteries
29 Mar 2026
Nicola Ryan provides her take on the trial evaluating multi-modality imaging to determine underlying causes of MINOCA in women and men. The trial results were presented by Harmony R. Reynolds at ACC.26 in New Orleans and simultaneously published in Circulation.
Author
FFR or 3d-quantitative coronary angiography-based vessel-FFR guided revascularisation – The FAST III trial
28 Mar 2026
Chiara De Biase provides her take on the FAST III Trial presented by Joost Daemen at ACC.26 in New Orleans. She reviews the comparison between vFFR and FFR, highlighting key findings and their impact on revascularisation strategies.
Author
Transcatheter aortic valve implantation without routine percutaneous coronary intervention: A randomized controlled trial (PRO-TAVI Trial)
29 Mar 2026
Jonathan Curio provides his take on the PRO-TAVI trial presented by Michiel Voskuil at ACC.26 in New Orleans and simultaneously published in The Lancet.
Author
Protect the head to head trial: Randomized comparison of emboliner embolic protection catheter vs. sentinel cerebral protection system during transcatheter aortic valve replacement
28 Mar 2026
Alex Sticchi interviews Adam B. Greenbaum on the PROTECT head-to-head trial, comparing the new full-body Emboliner device with the first-generation Sentinel during TAVR, as presented at ACC.26 in New Orleans.
Author
Author
Intravascular ultrasound-guided or angiography-guided complex high-risk PCI – The IVUS CHIP trial
28 Mar 2026
Daniele Giacoppo reports and provides his perspective on the main results of the IVUS-CHIP trial, presented by Roberto Diletti from the Erasmus University Medical Center, Rotterdam, the Netherlands, during a Late-Breaking Trials session at the ACC.26 in New Orleans, and simultaneously published in the New England Journal of...
Author
Ivus or angiography guidance for PCI in complex coronary bifurcation lesions (DKCRUSH-VIII)
31 Mar 2026
Nicola Ryan provides her take on DKCRUSH-VIII, a randomised controlled trial comparing IVUS versus angiography guidance for PCI, predominantly using the DKCRUSH technique in patients with complex bifurcation lesions, as presented by Shaoliang Chen at ACC.26 in New Orleans.
Author
Atrial mitral and tricuspid regurgitation
23 Feb 2026
Register for free to this webinar on Thursday 9 April at 5:00pm with M. Adamo, M. Sitges and P. Lurz, D. Muraru and T. De Potter and learn about epidemiology and clinical presentation of combined MR and TR in patients with AF,...
Basil Levetan
How to perform ELASTA-Clip: lacerating M-TEER devices to enable TMVR
09 Mar 2026
Recurrent mitral regurgitation after M-TEER can create a challenging scenario. Discover the ELASTA-Clip technique and its key steps to enable TMVR!
Author
Author
Six-year outcomes after transcatheter vs surgical aortic valve replacement in low-risk patients with aortic stenosis
25 Feb 2026
The 6-year results of the Evolut Low Risk trial confirm the absence of significant differences in the composite primary endpoint between TAVR and surgery, but introduce an important nuance: the first signal of increased valve reintervention in the TAVR arm within this trial.
Reviewer
Paolo Ferraro
Castel Volturno, Italy
Michele Cimmino
Castel Volturno, Italy
Michele Albanese
Castel Volturno, Italy
Design that delivers the future of TAVI
13 Feb 2026 – From PCR Tokyo Valves 2026
This session presents the future of TAVI valve design, emphasizing supra-annular valve benefits, strategies for managing concomitant coronary artery disease, and redo-TAVI approaches tailored for long-term patient management.
Drug-coated balloon angioplasty vs up-front stenting for de novo CAD: 3-year follow-up of REC-CAGEFREE I trial
10 Mar 2026
The 3-year follow-up of the REC-CAGEFREE I trial demonstrated that a DCB-based strategy with rescue stenting was associated with a significantly higher rate of DOCE compared with contemporary DES implantation in patients with de novo, non-complex coronary artery disease.
Reviewer
Reviewer
Bioresorbable vascular scaffold versus metallic drug-eluting stent in patients at high risk of restenosis: final 7-year results of the COMPARE-ABSORB trial
10 Mar 2026
This study provides the longest available follow-up for first-generation bioresorbable vascular scaffolds and fails to demonstrate any late clinical advantage after complete scaffold resorption.
Reviewer
Learn from the experts: Evolut first implant technique and treatment strategies
15 Feb 2026 – From PCR Tokyo Valves 2026
This expert-led session offers an in-depth review of evolving clinical practices in aortic valve disease treatment, emphasizing the potential of the transcarotid approach as a primary alternative access route. It compares current strategies including TAVI, surgical aortic valve replacement (SAV), TAV-in-SAV, and TAVI explantation, while addressing...
Learn from the experts: lifetime management for Evolut first redo TAVI (TAV-in-TAV) and explant
14 Feb 2026 – From PCR Tokyo Valves 2026
This session offers an in-depth exploration of lifetime management strategies for patients undergoing Evolut first redo TAVI procedures, including TAV-in-TAV and explant techniques. It provides a comprehensive understanding of clinical decision-making algorithms, technical challenges, and key considerations for successful procedural planning and execution, supported by real-world...
